Kang Mo Kim
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis 93
- Hepatitis C virus research 43
- Liver Disease and Transplantation 38
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 88
- Hepatitis B Virus Studies 54
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 11
- Oncology top 2%
-
- Cancer Mechanisms and Therapy 12
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 28
- Co-authors
- Young‐Suk LimHan Chu LeeJu Hyun ShimYung Sang LeeDong Jin SuhYoung–Hwa ChungSung‐Gyu LeeDanbi Lee
- Journals
- Circulation (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Kang Mo Kim
177 papers receiving 7.1k citations
Peers
Comparison fields: 5 of 119
- Hepatology 5.0k
- Epidemiology 3.9k
- Cancer Research 937
- Oncology 1.2k
- Pathology and Forensic Medicine 732
Countries citing papers authored by Kang Mo Kim
This map shows the geographic impact of Kang Mo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Mo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Mo Kim more than expected).
Fields of papers citing papers by Kang Mo Kim
This network shows the impact of papers produced by Kang Mo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Mo Kim. The network helps show where Kang Mo Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kang Mo Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 26 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 68 | |
| 16 | 2021 | 28 | |
| 17 | 2021 | 15 | |
| 18 | 2020 | 35 | |
| 19 | 2018 | 65 | |
| 20 | The Role of Radiotherapy in the Treatment of Portal Vein Thrombosis from Advanced Hepatocellular Carcinoma. | 2007 | 3 |
About Kang Mo Kim
Kang Mo Kim is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 184 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (93 papers), Liver Disease Diagnosis and Treatment (88 papers), Hepatitis B Virus Studies (54 papers), Hepatitis C virus research (43 papers), Liver Disease and Transplantation (38 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Cancer Mechanisms and Therapy (12 papers) and Cancer, Lipids, and Metabolism (11 papers). The work is most often cited by research in Hepatology (5.0k citations), Epidemiology (3.9k citations) and Cancer Research (937 citations). Kang Mo Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Young‐Suk Lim, Han Chu Lee, Ju Hyun Shim, Yung Sang Lee, Dong Jin Suh, Young–Hwa Chung, Sung‐Gyu Lee, Danbi Lee, Jihyun An and Jung‐Hwan Yoon. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.